Cargando…
Uterine leiomyosarcoma with central nervous system metastases
Leiomyosarcoma (LMS) is a rare tumour and comprises 2–3% of all malignant uterus neoplasms [1]. Leiomyosarcoma is characterised by aggressive behaviour, high recurrence rates, and poor overall survival, despite multimodal treatment [3]. Surgery is the main treatment and consists of total abdominal h...
Autores principales: | Abrahão, Carina Meira, Maluf, Fernando Cotait |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350572/ https://www.ncbi.nlm.nih.gov/pubmed/25767563 http://dx.doi.org/10.3332/ecancer.2015.515 |
Ejemplares similares
-
Response to pembrolizumab in a heavily treated patient with metastatic ovarian carcinosarcoma
por: Zibetti Dal Molin, Graziela, et al.
Publicado: (2018) -
Uterine tumors resembling ovarian sex-cord tumor: A case-report and a review of literature
por: Gomes, Jéssica Ribeiro, et al.
Publicado: (2015) -
Pancreatic metastases originating from uterine leiomyosarcoma: a case report
por: Dima, Simona Olimpia, et al.
Publicado: (2014) -
Spontaneous Tumor Lysis Syndrome due to Uterine Leiomyosarcoma with Lung Metastases
por: Alaigh, Vivek, et al.
Publicado: (2017) -
Uterine leiomyosarcoma: A case report
por: Kaur, Khushpreet, et al.
Publicado: (2014)